Literature DB >> 2172069

Different type of hepatitis B virus (HBV) DNA integrants that may reflect the integration process.

K Okubo1, T Nakamura, T Tokino, K Matsubara.   

Abstract

Through analyses of HBV DNA integratns in human cellular DNA, we identified three different integrant types, each of which may reflect the process of primary integrant formation by the viral DNA. The first type, which we call "simple type" consists of integrants found in some hepatocellular carcinomas (HCC's). The structure of the viral genome is simple, and part of it is deleted. The viral cohesive end sequence appears at one of the viral-cellular DNA junctions, and integration has elicited a microdeletion in the target cellular DNA sequence. This structure suggests viral DNA replication intermediates as substrates for integration. Judging from its frequency in HCC, this type may represent the most preferred one, if not all, among the primary integration products. The second type, which we call "complex type" is essentially the same as the first type, except tht the viral genome structure is complex. We considered the possibility that they may have been produced via the same process, using preformed complex viral genomes such as "novel form DNA's" (Rogler and Summers, 1982) as substrates. In cultured fetal hepatocytes, integration of HBV DNA can occur only a few days after infection. Among such integrants, we found a third type integrant, having a simple viral genome, but having a larger cellular DNA deletion. We propose that different forms of viral DNA may be used as substrates in the integration process, and the process is characterized by its eliciting of deletions of different size in the target cellular DNA. The most preferred substrate may be the one producing the simple type integrants, and the most frequently occurring deletion in the target DNA may be the microdeletion.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2172069     DOI: 10.1007/BF02779924

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  25 in total

1.  Chromosomal translocation and inverted duplication associated with integrated hepatitis B virus in hepatocellular carcinomas.

Authors:  T Tokino; S Fukushige; T Nakamura; T Nagaya; T Murotsu; K Shiga; N Aoki; K Matsubara
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

2.  The mode of hepatitis B virus DNA integration in chromosomes of human hepatocellular carcinoma.

Authors:  T Nagaya; T Nakamura; T Tokino; T Tsurimoto; M Imai; T Mayumi; K Kamino; K Yamamura; K Matsubara
Journal:  Genes Dev       Date:  1987-10       Impact factor: 11.361

3.  Stable expression and replication of hepatitis B virus genome in an integrated state in a human hepatoma cell line transfected with the cloned viral DNA.

Authors:  T Tsurimoto; A Fujiyama; K Matsubara
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

4.  Hepatitis B virus integration in hepatocellular carcinoma DNA: duplication of cellular flanking sequences at the integration site.

Authors:  K Yaginuma; M Kobayashi; E Yoshida; K Koike
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

5.  Immortalization of xeroderma pigmentosum cells by simian virus 40 DNA having a defective origin of DNA replication.

Authors:  D Canaani; T Naiman; T Teitz; P Berg
Journal:  Somat Cell Mol Genet       Date:  1986-01

Review 6.  Integration of hepatitis B virus DNA and its implications for hepatocarcinogenesis.

Authors:  K Matsubara; T Tokino
Journal:  Mol Biol Med       Date:  1990-06

7.  Hepatitis B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in a hepatocellular carcinoma.

Authors:  A Dejean; L Bougueleret; K H Grzeschik; P Tiollais
Journal:  Nature       Date:  1986 Jul 3-9       Impact factor: 49.962

8.  An in vitro system for infection with hepatitis B virus that uses primary human fetal hepatocytes.

Authors:  T Ochiya; T Tsurimoto; K Ueda; K Okubo; M Shiozawa; K Matsubara
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Deletion in chromosome 11p associated with a hepatitis B integration site in hepatocellular carcinoma.

Authors:  C E Rogler; M Sherman; C Y Su; D A Shafritz; J Summers; T B Shows; A Henderson; M Kew
Journal:  Science       Date:  1985-10-18       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.